tiprankstipranks
Amedisys Inc (AMED)
NASDAQ:AMED
US Market

Amedisys (AMED) Income Statement

Compare
455 Followers

Amedisys Income Statement

Last quarter (Q3 2024), Amedisys's total revenue was $587.67M, an increase of 5.65% from the same quarter last year. In Q3, Amedisys's net income was $41.46M. See Amedisys’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.24B$ 2.22B$ 2.21B$ 2.07B$ 1.96B
Gross Profit
$ 990.87M$ 962.77M$ 980.76M$ 886.15M$ 805.30M
Operating Expenses
$ 834.48M$ 778.99M$ 728.84M$ 662.73M$ 626.35M
Depreciation and Amortization
$ 23.85M$ 24.93M$ 30.90M$ 28.80M$ 18.43M
EBITDA
$ 216.91M$ 207.41M$ 320.66M$ 250.66M$ 203.35M
Operating Income
$ 156.39M$ 180.77M$ 251.91M$ 219.27M$ 177.47M
Other Income/Expenses
$ -116.77M$ -20.53M$ 28.32M$ -8.45M$ -7.06M
Pretax Income
$ 39.62M$ 160.24M$ 280.23M$ 210.82M$ 170.41M
Net Income
$ -9.75M$ 118.61M$ 209.07M$ 183.61M$ 126.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.30$ 3.65$ 6.41$ 5.64$ 3.95
Diluted EPS
$ -0.30$ 3.63$ 6.34$ 5.52$ 3.84
Weighted Average Shares Outstanding
32.49M 32.52M 32.64M 32.56M 32.14M
Weighted Average Shares Outstanding (Diluted)
32.60M 32.65M 32.97M 33.27M 32.99M
Currency in USD

Amedisys Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis